ID

43345

Descripción

ODM derived from http://clinicaltrials.gov/show/NCT00359762

Link

http://clinicaltrials.gov/show/NCT00359762

Palabras clave

  1. 22/3/12 22/3/12 -
  2. 14/4/14 14/4/14 - Julian Varghese
  3. 20/9/21 20/9/21 -
Subido en

20 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility NCT00359762 Type 2 Diabetes Mellitus

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Einschlusskriterien
Descripción

Einschlusskriterien

age 18 Years to 85 Years
Descripción

age 18 Years to 85 Years

Tipo de datos

boolean

Alias
UMLS CUI 2011AA
C0001779
SNOMED CT 2011_0131
397669002
Diagnosed with type 2 diabetes mellitus.
Descripción

Diagnosed with type 2 diabetes mellitus.

Tipo de datos

boolean

Alias
UMLS CUI 2011AA
C0011900
SNOMED CT 2011_0131
439401001
LOINC Version 232
MTHU008876
UMLS CUI 2011AA
C0011860
SNOMED CT 2011_0131
44054006
MedDRA 14.1
10012613
ICD-10-CM Version 2010
E08-E13
Treated with diet and exercise and a stable, maximally tolerated dose of metformin for at least 3 months prior to screening.
Descripción

Treated with diet and exercise and a stable, maximally tolerated dose of metformin for at least 3 months prior to screening.

Tipo de datos

boolean

Alias
UMLS CUI 2011AA
C0012155
SNOMED CT 2011_0131
41829006
UMLS CUI 2011AA
C0015259
SNOMED CT 2011_0131
256235009
MedDRA 14.1
10015634
UMLS CUI 2011AA
C0205360
SNOMED CT 2011_0131
58158008
LOINC Version 232
MTHU015276
UMLS CUI 2011AA
C0013227
UMLS CUI 2011AA
C0025598
SNOMED CT 2011_0131
372567009
LOINC Version 232
MTHU016062
HbA1c >=6.5% und <=9.0%.
Descripción

HbA1c >=6.5% and <=9.0%.

Tipo de datos

boolean

Alias
UMLS CUI 2011AA
C0019018
SNOMED CT 2011_0131
33601001
LOINC Version 232
MTHU018890
Body Mass Index (BMI) >=25 kg/m2 und <40 kg/m2.
Descripción

Body Mass Index (BMI) >=25 kg/m2 and <40 kg/m2.

Tipo de datos

boolean

Alias
UMLS CUI 2011AA
C1305855
SNOMED CT 2011_0131
140075008
MedDRA 14.1
10005894
LOINC Version 232
LP35925-4
Ausschlusskriterien
Descripción

Ausschlusskriterien

Participated in an interventional medical, surgical, or pharmaceutical study within 30 days prior to screening.
Descripción

Participated in an interventional medical, surgical, or pharmaceutical study within 30 days prior to screening.

Tipo de datos

boolean

Alias
UMLS CUI 2011AA
C2348568
Characteristics contraindicating metformin or glimepiride use.
Descripción

Characteristics contraindicating metformin or glimepiride use.

Tipo de datos

boolean

Alias
UMLS CUI 2011AA
C1301624
SNOMED CT 2011_0131
397745006
UMLS CUI 2011AA
C0025598
SNOMED CT 2011_0131
372567009
LOINC Version 232
MTHU016062
UMLS CUI 2011AA
C0061323
SNOMED CT 2011_0131
386966003
LOINC Version 232
MTHU018302
Receiving drugs that directly affect gastrointestinal motility.
Descripción

Receiving drugs that directly affect gastrointestinal motility.

Tipo de datos

boolean

Alias
UMLS CUI 2011AA
C0013227
UMLS CUI 2011AA
C0017184
Receiving chronic (lasting longer than 2 weeks) systemic glucocorticoid therapy.
Descripción

Receiving chronic (lasting longer than 2 weeks) systemic glucocorticoid therapy.

Tipo de datos

boolean

Alias
UMLS CUI 2011AA
C0205191
SNOMED CT 2011_0131
90734009
UMLS CUI 2011AA
CL383594
Have used any prescription drug to promote weight loss within 3 months prior to screening.
Descripción

Have used any prescription drug to promote weight loss within 3 months prior to screening.

Tipo de datos

boolean

Alias
UMLS CUI 2011AA
C0013227
UMLS CUI 2011AA
C1262477
SNOMED CT 2011_0131
89362005
MedDRA 14.1
10047895
LOINC Version 232
MTHU020881
ICD-9-CM Version 2011
783.21
CTCAE 1105E
E12228
Descripción

Treated for longer than 2 weeks with any of the following medications within 3 months prior to screening: insulin, thiazolidinediones, alpha-glucosidase inhibitors, sulfonylurea, meglitinides

Tipo de datos

boolean

Alias
UMLS CUI 2011AA
C0013227
UMLS CUI 2011AA
C0021641
SNOMED CT 2011_0131
67866001
LOINC Version 232
MTHU019392
UMLS CUI 2011AA
C1257987
SNOMED CT 2011_0131
109086001
UMLS CUI 2011AA
C2267008
UMLS CUI 2011AA
C0038766
UMLS CUI 2011AA
C1579432

Similar models

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Einschlusskriterien
age 18 Years to 85 Years
Item
age 18 Years to 85 Years
boolean
C0001779 (UMLS CUI 2011AA)
397669002 (SNOMED CT 2011_0131)
Diagnosed with type 2 diabetes mellitus.
Item
Diagnosed with type 2 diabetes mellitus.
boolean
C0011900 (UMLS CUI 2011AA)
439401001 (SNOMED CT 2011_0131)
MTHU008876 (LOINC Version 232)
C0011860 (UMLS CUI 2011AA)
44054006 (SNOMED CT 2011_0131)
10012613 (MedDRA 14.1)
E08-E13 (ICD-10-CM Version 2010)
Treated with diet and exercise and a stable, maximally tolerated dose of metformin for at least 3 months prior to screening.
Item
Treated with diet and exercise and a stable, maximally tolerated dose of metformin for at least 3 months prior to screening.
boolean
C0012155 (UMLS CUI 2011AA)
41829006 (SNOMED CT 2011_0131)
C0015259 (UMLS CUI 2011AA)
256235009 (SNOMED CT 2011_0131)
10015634 (MedDRA 14.1)
C0205360 (UMLS CUI 2011AA)
58158008 (SNOMED CT 2011_0131)
MTHU015276 (LOINC Version 232)
C0013227 (UMLS CUI 2011AA)
C0025598 (UMLS CUI 2011AA)
372567009 (SNOMED CT 2011_0131)
MTHU016062 (LOINC Version 232)
HbA1c >=6.5% and <=9.0%.
Item
HbA1c >=6.5% und <=9.0%.
boolean
C0019018 (UMLS CUI 2011AA)
33601001 (SNOMED CT 2011_0131)
MTHU018890 (LOINC Version 232)
Body Mass Index (BMI) >=25 kg/m2 and <40 kg/m2.
Item
Body Mass Index (BMI) >=25 kg/m2 und <40 kg/m2.
boolean
C1305855 (UMLS CUI 2011AA)
140075008 (SNOMED CT 2011_0131)
10005894 (MedDRA 14.1)
LP35925-4 (LOINC Version 232)
Item Group
Ausschlusskriterien
Participated in an interventional medical, surgical, or pharmaceutical study within 30 days prior to screening.
Item
Participated in an interventional medical, surgical, or pharmaceutical study within 30 days prior to screening.
boolean
C2348568 (UMLS CUI 2011AA)
Characteristics contraindicating metformin or glimepiride use.
Item
Characteristics contraindicating metformin or glimepiride use.
boolean
C1301624 (UMLS CUI 2011AA)
397745006 (SNOMED CT 2011_0131)
C0025598 (UMLS CUI 2011AA)
372567009 (SNOMED CT 2011_0131)
MTHU016062 (LOINC Version 232)
C0061323 (UMLS CUI 2011AA)
386966003 (SNOMED CT 2011_0131)
MTHU018302 (LOINC Version 232)
Receiving drugs that directly affect gastrointestinal motility.
Item
Receiving drugs that directly affect gastrointestinal motility.
boolean
C0013227 (UMLS CUI 2011AA)
C0017184 (UMLS CUI 2011AA)
Receiving chronic (lasting longer than 2 weeks) systemic glucocorticoid therapy.
Item
Receiving chronic (lasting longer than 2 weeks) systemic glucocorticoid therapy.
boolean
C0205191 (UMLS CUI 2011AA)
90734009 (SNOMED CT 2011_0131)
CL383594 (UMLS CUI 2011AA)
Have used any prescription drug to promote weight loss within 3 months prior to screening.
Item
Have used any prescription drug to promote weight loss within 3 months prior to screening.
boolean
C0013227 (UMLS CUI 2011AA)
C1262477 (UMLS CUI 2011AA)
89362005 (SNOMED CT 2011_0131)
10047895 (MedDRA 14.1)
MTHU020881 (LOINC Version 232)
783.21 (ICD-9-CM Version 2011)
E12228 (CTCAE 1105E)
Treated for longer than 2 weeks with any of the following medications within 3 months prior to screening: insulin, thiazolidinediones, alpha-glucosidase inhibitors, sulfonylurea, meglitinides
Item
boolean
C0013227 (UMLS CUI 2011AA)
C0021641 (UMLS CUI 2011AA)
67866001 (SNOMED CT 2011_0131)
MTHU019392 (LOINC Version 232)
C1257987 (UMLS CUI 2011AA)
109086001 (SNOMED CT 2011_0131)
C2267008 (UMLS CUI 2011AA)
C0038766 (UMLS CUI 2011AA)
C1579432 (UMLS CUI 2011AA)

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial